PAXIP1 Antikörper (N-Term)
Kurzübersicht für PAXIP1 Antikörper (N-Term) (ABIN928548)
Target
Alle PAXIP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Rind (Kuh), Hund, Frosch, Zebrafisch (Brachydanio rerio)
-
Aufreinigung
- Purified
-
Immunogen
- PAXIP1 antibody was raised in rabbit using the N terminal of PAXIP1 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
PAXIP1 Blocking Peptide, (ABIN5615226), is also available for use as a blocking control in assays to test for specificity of this PAXIP1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PAXIP1 (PAX Interacting (With Transcription-Activation Domain) Protein 1 (PAXIP1))
-
Andere Bezeichnung
- PAXIP1
-
Hintergrund
- PAXIP1 functions as a key component of the DNA damage response, and phosphoserine or phosphothreonine-specific binding modules. PAXIP1 recognizes substrates phosphorylated by the kinases ataxia telangiectasia-mutated (ATM), ataxia telangiectasia and RAD3-related (ATR) in response to gamma irradiation. It may play a role in PAX2-dependent transcriptional regulation. PAXIP1 plays a role in early development, most probably in cell proliferation. Synonyms: Polyclonal PAXIP1 antibody, Anti-PAXIP1 antibody, PAX interacting, with transcription-activation domain protein 1 antibody, PTIP antibody, TNRC2 antibody, CAGF28 antibody, CAGF29 antibody, PACIP1 antibody, PAXIP1L antibody, FLJ41049 antibody.
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Target
-